1 / 33

Joint Hospital Surgical Grand Round

Joint Hospital Surgical Grand Round. Chiu Hiu Fung Jennifer Kwong Wah Hospital 25-1-2014. Is Breast Conserving Treatment (BCT) feasible for Ipsilateral Breast Tumour Recurrence (IBTR)?. Breast conserving surgery. BCT = wide local excision + radiotherapy

stevenstewart
Télécharger la présentation

Joint Hospital Surgical Grand Round

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Joint Hospital Surgical Grand Round • Chiu Hiu Fung Jennifer • Kwong Wah Hospital • 25-1-2014

  2. Is Breast Conserving Treatment (BCT) feasible for Ipsilateral Breast Tumour Recurrence (IBTR)?

  3. Breast conserving surgery • BCT = wide local excision + radiotherapy • Well-established treatment modality for early breast cancer • Equal local control and disease-free survival compared to mastectomy • Superior psychosocial outcomes - improved body image and lifestyle score National Surgical Adjuvant Breast and Bowel Project (NSABP) B-06 trial

  4. Definition of local recurrence • IBTR - recurrent tumour within the ipsilateral breast after lumpectomy + radiotherapy • Recurrence within 6 months of primary surgery - primary treatment failure • Local recurrence - recurrence after mastectomy ie skin / chest wall • True recurrence (TR) vs New primary (NP)

  5. Ipsilateral breast tumour recurrence (IBTR) rate after BCS + RT is 1-2% per year • In 1990s, IBTR rate after BCS (without RT) at 10 years: 19% • In 2000s, IBTR rate after BCS + RT at 10 years: 9% NSABP B-17 and B-24 trials

  6. Risk factors for first recurrence: • Omission of radiotherapy • Young age • Involved margin • Multifocality • Extensive in-situ component • Lymphovascular invasion

  7. No standard classification of True Recurrence (TR) vs New Primary (NP) • Different classifications include: • tumour location • histological subtype • ER status • DNA flow cytometry • Gene expression profiling data

  8. True Recurrences: 44 - 78% • TR - shorter metastasis-free survival • mean time to disease recurrence - • 37 months for TRs vs 55 months for NPs Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: New primary cancer allows a good prognosis. Nishimura S. Cancer 2005;12:112–117.

  9. True recurrence is a poor prognostic factor - agressive biology intrinsic to the tumour itself • Lower overall survival and disease-free survival compared to NP group • Hypothesis that TR and NP tumours are distinct entities with different survival prognoses requires further confirmation with pathology review and molecular analyses Analysis of Ipsilateral Breast Tumor Recurrences after Breast-conserving Treatment Based on the Classification of True Recurrences and New Primary Tumors. Komoike Y. Breast Cancer. 2005;12(2):104-111.

  10. Treatment options for IBTR • Salvage mastectomy - gold standard of local treatment for IBTR • Second local recurrence rate: 10% (3-32%) • 5 year disease free survival: 41-59% • 5 year overall survival: 70% (58-84%)

  11. Is there any role for repeating BCS for IBTR? Is it safe?

  12. <local treatment options for IBTR>

  13. Four different salvage options were analyzed: • (a) Salvage mastectomy alone • (b) Salvage mastectomy + re-irradiation • (c) 2nd BCS alone • (d) 2nd BCS + re-irradiation

  14. Methods of Re-irradiation • Conventional external beam re-irradiation • Interstitial brachytherapy • low dose rate, high dose rate, or pulsed dose rate • Intra-operative radiotherapy

  15. Salvage mastectomy alone for IBTR • Second local recurrence rate 10-15% (3 - 32%) • 10 year disease free survival: 40-45% (61 - 84%)

  16. Second bcs without post-operative re-irradiation • Second local recurrence rate: 20% (7 - 32%) • 10 year disease free survival: 60% (61 - 64%) Second BCS without re-irradiation is associated with more second local recurrence and less 10 year overall survival when compared to salvage mastectomy

  17. Second bcs with post-operative re-irradiation for IBTR • Second local recurrence rate: 2 - 26% • 5 year overall survival: 75% (61 - 97%) Grade 3-4 toxicity: 3 - 11%

  18. Salvage mastectomy vs second BCS + Re-irradiation • Second local recurrence rate is similar (about 10%) • 5 year overall survival is similar, mainly influenced by distant metastatic progression • Difficult to conduct a randomized controlled trial • Large number of patients will be needed as IBTR is a rare event • Patient may not accept randomization between salvage mastectomy and second BCT

  19. What are the risk factors for second local recurrence?

  20. Retrospective analysis • 3155 patients with DCIS or IDC underwent breast conserving surgery from 1986 - 2010 • 132 developed IBTR (~3%) • 46 underwent salvage mastectomy, remaining 86 received second BCS • 8 patients that did not receive re-irradiation were excluded • Total of 78 patient with IBTR and were treated with second BCS + re-irradiation • 17 of 78 patients experienced second IBTR

  21. Time >2 years ER +ve negative margins age at diagnosis >40 years ER +ve

  22. Low risk: DFI > 2 years, ER positive or unknown, negative margins, and age at initial diagnosis >=40

  23. Which type of patients are suitable for second BCS + re-irradiation?

  24. Controversial... • Time to recurrence >2 years • Positive ER status • ? new primary tumors • Sizeable breasts

  25. Conclusion • Both salvage mastectomy and second BCS + re-irradiation are treatment options of IBTR • Still need further large scale studies to compare local recurrence rate and overall survival • To identify the group of patients who can benefit from second BCT • Develop newer radiation techniques to reduce re-irradiation toxicity

  26. References • Local treatment options for ipsilateral breast tumour recurrence. Hannoun-Levi JM. Cancer Treat Rev. 2013 Nov;39(7):737-41. • Analysis of Ipsilateral Breast Tumor Recurrences after Breast-conserving Treatment Based on the Classification of True Recurrences and New Primary Tumors. Komoike Y. Breast Cancer. 2005;12(2):104-111. • Repeat Lumpectomy for Ipsilateral Breast Tumor Recurrence after Breast-Conserving Treatment. Ishitobi M. Oncology. 2011;81:381-386 • True Recurrence Versus New Primary: An Analysis of Ipsilateral Breast Tumor Recurrences After Breast-Conserving Therapy. V Panet-Raymond. International Journal of Radiation Oncology. 2011;81(2):409-41 • Repeating Conservative Surgery after Ipsilateral Breast Tumor Reappearance: Criteria for Selecting the Best Candidates. Gentilini O. Ann Surg Oncol. 2012;19:3771-3776

  27. The End

  28. interstitial brachytherapy • Brachy: short-distance • Can be used alone or in combination with surgery, external beam RT and chemotherapy

  29. Intraoperative radiotherapy (IORT)

  30. IORT group: 1 dose 21 Gy during surgery • External RT group: 50 Gy in 25 fractions of 2 Gy + boost of 10 Gy in 5 fractions • 5-year rate for IBTR 4.4% for IORT group; 0.4% for external RT • Same overall survival • Significantly fewer skin side-effects in IORT group (p=0.0002)

  31. Toxicity of irradiation • radiation dermatitis, fibrosis, telangiectasia • pericarditis, pericardial effusion, pneumonitis • From double surgery: asymmetry

More Related